Quest Diagnostics Incorporated (DGX)
Largest Insider Buys in Sector
DGX Stock Price History Chart
DGX Stock Performance
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent …
Insider Activity of Quest Diagnostics Incorporated
Over the last 12 months, insiders at Quest Diagnostics Incorporated have bought $0 and sold $8M worth of Quest Diagnostics Incorporated stock.
On average, over the past 5 years, insiders at Quest Diagnostics Incorporated have bought $0 and sold $55.7M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 8,000 shares for transaction amount of $444,046 was made by GUINAN MARK (Senior Vice President & CFO) on 2014‑05‑05.
List of Insider Buy and Sell Transactions, Quest Diagnostics Incorporated
| 2024-10-28 | Sale | SVP, Clinical Solutions | 1,775 0.0016% | $156.92 | $278,525 | 0.00% | ||
| 2024-08-29 | Sale | SVP & General Counsel | 32,551 0.029% | $154.97 | $5.04M | -1.28% | ||
| 2024-08-28 | Sale | SVP, Clinical Solutions | 1,990 0.0018% | $153.26 | $304,990 | -0.40% | ||
| 2024-07-24 | Sale | SVP & Chief Commercial Officer | 420 0.0004% | $143.08 | $60,094 | +0.46% | ||
| 2024-04-29 | Sale | SVP, Clinical Solutions | 1,760 0.0016% | $140.00 | $246,400 | +5.72% | ||
| 2024-02-29 | Sale | EVP, Regional Businesses | 1,187 0.0011% | $125.88 | $149,420 | +13.45% | ||
| 2024-02-29 | Sale | SVP & General Counsel | 5,611 0.0051% | $125.88 | $706,313 | +13.45% | ||
| 2024-02-28 | Sale | EVP, Regional Businesses | 5,557 0.0051% | $126.57 | $703,349 | +12.62% | ||
| 2024-02-23 | Sale | director | 2,500 0.0022% | $126.64 | $316,597 | +11.16% | ||
| 2024-02-22 | Sale | EVP, Regional Businesses | 821 0.0007% | $126.14 | $103,561 | +12.65% | ||
| 2024-02-22 | Sale | SVP & General Counsel | 661 0.0006% | $126.14 | $83,379 | +12.65% | ||
| 2023-03-07 | Sale | SVP, Regional Businesses | 5,307 0.0048% | $140.55 | $745,899 | -1.82% | ||
| 2023-03-07 | Sale | SVP & General Counsel | 4,754 0.0043% | $140.55 | $668,175 | -1.82% | ||
| 2023-03-03 | Sale | SVP, Regional Businesses | 717 0.0006% | $140.63 | $100,832 | -3.84% | ||
| 2023-03-02 | Sale | SVP & General Counsel | 593 0.0005% | $138.54 | $82,154 | -3.09% | ||
| 2023-02-24 | Sale | SVP, Regional Businesses | 1,690 0.0015% | $141.42 | $239,000 | -2.95% | ||
| 2023-02-24 | Sale | SVP & General Counsel | 1,415 0.0013% | $141.42 | $200,109 | -2.95% | ||
| 2022-12-01 | Sale | director | 2,025 0.0017% | $152.50 | $308,813 | -9.67% | ||
| 2022-11-28 | Sale | SVP, Regional Businesses | 40,765 0.0352% | $149.18 | $6.08M | -7.47% | ||
| 2022-11-01 | Sale | director | 2,000 0.0017% | $144.06 | $288,120 | -1.87% |
Insider Historical Profitability
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 334833 0.3% | $154.86 | 2 | 16 | +0.94% |
| GUINAN MARK | Executive Vice President & CFO | 73579 0.0659% | $154.86 | 1 | 5 | +14.91% |
| STANZIONE DANIEL | director | 28349 0.0254% | $154.86 | 1 | 9 | +6.37% |
| BONGIORNO THOMAS F | VP and Corporate Controller | 12477 0.0112% | $154.86 | 1 | 24 | +3.61% |
| MAIN TIMOTHY L | director | 5658 0.0051% | $154.86 | 1 | 0 | +20.26% |
Institutional Investor Ownership
| The Vanguard Group | $1.85B | 12.53 | 13.92M | +2.55% | +$46.02M | 0.03 | |
| BlackRock | $1.42B | 9.63 | 10.7M | +1.16% | +$16.27M | 0.03 | |
| State Street | $692.06M | 4.68 | 5.2M | -2.46% | -$17.43M | 0.03 | |
| Victory Capital Management Inc | $522.1M | 3.53 | 3.92M | +12.82% | +$59.33M | 0.53 | |
| American Century Investments | $515.63M | 3.49 | 3.87M | +7.01% | +$33.76M | 0.32 |